酢酸ランレオチドのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Lanreotide Acetate Market Insights and Forecast to 2027

• レポートコード：QY2112C00267 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は酢酸ランレオチドの世界市場の現状について調査・分析し、2027年までの市場を予測しました。酢酸ランレオチドの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度98％以上、その他）、用途別市場規模（先端巨大症、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・酢酸ランレオチドの世界市場概要 ・メーカー別の競争状況、市場シェア ・酢酸ランレオチドの種類別市場規模：純度98％以上、その他 ・酢酸ランレオチドの用途別市場規模：先端巨大症、その他 ・北米の酢酸ランレオチド市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの酢酸ランレオチド市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの酢酸ランレオチド市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の酢酸ランレオチド市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの酢酸ランレオチド市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Bachem、Jiangsu Sinopep Allsino Biopharmaceutical、Chinese Peptide Company、ZHEJIANG HUAJUN PHARMACEUTICAL ・酢酸ランレオチドのバリューチェーン・販売チャネル分析 ・酢酸ランレオチドの世界市場動向

Market Analysis and Insights: Global Lanreotide Acetate Market
The global Lanreotide Acetate market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Lanreotide Acetate Scope and Segment
Lanreotide Acetate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lanreotide Acetate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
≥98% Purity
Other

Segment by Application
Acromegaly
Other

By Company
Bachem
Jiangsu Sinopep Allsino Biopharmaceutical
Chinese Peptide Company
ZHEJIANG HUAJUN PHARMACEUTICAL

Production by Region
North America
Europe
China

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Lanreotide Acetate Product Introduction
1.2 Market by Type
1.2.1 Global Lanreotide Acetate Market Size Growth Rate by Type
1.2.2 ≥98% Purity
1.2.3 Other
1.3 Market by Application
1.3.1 Global Lanreotide Acetate Market Size Growth Rate by Application
1.3.2 Acromegaly
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Lanreotide Acetate Production
2.1 Global Lanreotide Acetate Production Capacity (2016-2027)
2.2 Global Lanreotide Acetate Production by Region: 2016 VS 2021 VS 2027
2.3 Global Lanreotide Acetate Production by Region
2.3.1 Global Lanreotide Acetate Historic Production by Region (2016-2021)
2.3.2 Global Lanreotide Acetate Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China

3 Global Lanreotide Acetate Sales in Volume & Value Estimates and Forecasts
3.1 Global Lanreotide Acetate Sales Estimates and Forecasts 2016-2027
3.2 Global Lanreotide Acetate Revenue Estimates and Forecasts 2016-2027
3.3 Global Lanreotide Acetate Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Lanreotide Acetate Regions by Sales
3.4.1 Global Top Lanreotide Acetate Regions by Sales (2016-2021)
3.4.2 Global Top Lanreotide Acetate Regions by Sales (2022-2027)
3.5 Global Top Lanreotide Acetate Regions by Revenue
3.5.1 Global Top Lanreotide Acetate Regions by Revenue (2016-2021)
3.5.2 Global Top Lanreotide Acetate Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global Lanreotide Acetate Production Capacity by Manufacturers
4.2 Global Lanreotide Acetate Sales by Manufacturers
4.2.1 Global Top Lanreotide Acetate Manufacturers by Sales (2016-2021)
4.2.2 Global Top Lanreotide Acetate Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Lanreotide Acetate Sales in 2020
4.3 Global Lanreotide Acetate Revenue by Manufacturers
4.3.1 Global Top Lanreotide Acetate Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Lanreotide Acetate Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Lanreotide Acetate Revenue in 2020
4.4 Global Lanreotide Acetate Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Lanreotide Acetate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Lanreotide Acetate Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Lanreotide Acetate Sales by Type
5.1.1 Global Lanreotide Acetate Historical Sales by Type (2016-2021)
5.1.2 Global Lanreotide Acetate Forecasted Sales by Type (2022-2027)
5.1.3 Global Lanreotide Acetate Sales Market Share by Type (2016-2027)
5.2 Global Lanreotide Acetate Revenue by Type
5.2.1 Global Lanreotide Acetate Historical Revenue by Type (2016-2021)
5.2.2 Global Lanreotide Acetate Forecasted Revenue by Type (2022-2027)
5.2.3 Global Lanreotide Acetate Revenue Market Share by Type (2016-2027)
5.3 Global Lanreotide Acetate Price by Type
5.3.1 Global Lanreotide Acetate Price by Type (2016-2021)
5.3.2 Global Lanreotide Acetate Price Forecast by Type (2022-2027)

6 Market Size by Application
6.1 Global Lanreotide Acetate Sales by Application
6.1.1 Global Lanreotide Acetate Historical Sales by Application (2016-2021)
6.1.2 Global Lanreotide Acetate Forecasted Sales by Application (2022-2027)
6.1.3 Global Lanreotide Acetate Sales Market Share by Application (2016-2027)
6.2 Global Lanreotide Acetate Revenue by Application
6.2.1 Global Lanreotide Acetate Historical Revenue by Application (2016-2021)
6.2.2 Global Lanreotide Acetate Forecasted Revenue by Application (2022-2027)
6.2.3 Global Lanreotide Acetate Revenue Market Share by Application (2016-2027)
6.3 Global Lanreotide Acetate Price by Application
6.3.1 Global Lanreotide Acetate Price by Application (2016-2021)
6.3.2 Global Lanreotide Acetate Price Forecast by Application (2022-2027)

7 North America
7.1 North America Lanreotide Acetate Market Size by Type
7.1.1 North America Lanreotide Acetate Sales by Type (2016-2027)
7.1.2 North America Lanreotide Acetate Revenue by Type (2016-2027)
7.2 North America Lanreotide Acetate Market Size by Application
7.2.1 North America Lanreotide Acetate Sales by Application (2016-2027)
7.2.2 North America Lanreotide Acetate Revenue by Application (2016-2027)
7.3 North America Lanreotide Acetate Sales by Country
7.3.1 North America Lanreotide Acetate Sales by Country (2016-2027)
7.3.2 North America Lanreotide Acetate Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe Lanreotide Acetate Market Size by Type
8.1.1 Europe Lanreotide Acetate Sales by Type (2016-2027)
8.1.2 Europe Lanreotide Acetate Revenue by Type (2016-2027)
8.2 Europe Lanreotide Acetate Market Size by Application
8.2.1 Europe Lanreotide Acetate Sales by Application (2016-2027)
8.2.2 Europe Lanreotide Acetate Revenue by Application (2016-2027)
8.3 Europe Lanreotide Acetate Sales by Country
8.3.1 Europe Lanreotide Acetate Sales by Country (2016-2027)
8.3.2 Europe Lanreotide Acetate Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific Lanreotide Acetate Market Size by Type
9.1.1 Asia Pacific Lanreotide Acetate Sales by Type (2016-2027)
9.1.2 Asia Pacific Lanreotide Acetate Revenue by Type (2016-2027)
9.2 Asia Pacific Lanreotide Acetate Market Size by Application
9.2.1 Asia Pacific Lanreotide Acetate Sales by Application (2016-2027)
9.2.2 Asia Pacific Lanreotide Acetate Revenue by Application (2016-2027)
9.3 Asia Pacific Lanreotide Acetate Sales by Region
9.3.1 Asia Pacific Lanreotide Acetate Sales by Region (2016-2027)
9.3.2 Asia Pacific Lanreotide Acetate Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America Lanreotide Acetate Market Size by Type
10.1.1 Latin America Lanreotide Acetate Sales by Type (2016-2027)
10.1.2 Latin America Lanreotide Acetate Revenue by Type (2016-2027)
10.2 Latin America Lanreotide Acetate Market Size by Application
10.2.1 Latin America Lanreotide Acetate Sales by Application (2016-2027)
10.2.2 Latin America Lanreotide Acetate Revenue by Application (2016-2027)
10.3 Latin America Lanreotide Acetate Sales by Country
10.3.1 Latin America Lanreotide Acetate Sales by Country (2016-2027)
10.3.2 Latin America Lanreotide Acetate Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Lanreotide Acetate Market Size by Type
11.1.1 Middle East and Africa Lanreotide Acetate Sales by Type (2016-2027)
11.1.2 Middle East and Africa Lanreotide Acetate Revenue by Type (2016-2027)
11.2 Middle East and Africa Lanreotide Acetate Market Size by Application
11.2.1 Middle East and Africa Lanreotide Acetate Sales by Application (2016-2027)
11.2.2 Middle East and Africa Lanreotide Acetate Revenue by Application (2016-2027)
11.3 Middle East and Africa Lanreotide Acetate Sales by Country
11.3.1 Middle East and Africa Lanreotide Acetate Sales by Country (2016-2027)
11.3.2 Middle East and Africa Lanreotide Acetate Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 Bachem
12.1.1 Bachem Corporation Information
12.1.2 Bachem Overview
12.1.3 Bachem Lanreotide Acetate Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Bachem Lanreotide Acetate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Bachem Recent Developments
12.2 Jiangsu Sinopep Allsino Biopharmaceutical
12.2.1 Jiangsu Sinopep Allsino Biopharmaceutical Corporation Information
12.2.2 Jiangsu Sinopep Allsino Biopharmaceutical Overview
12.2.3 Jiangsu Sinopep Allsino Biopharmaceutical Lanreotide Acetate Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Jiangsu Sinopep Allsino Biopharmaceutical Lanreotide Acetate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Jiangsu Sinopep Allsino Biopharmaceutical Recent Developments
12.3 Chinese Peptide Company
12.3.1 Chinese Peptide Company Corporation Information
12.3.2 Chinese Peptide Company Overview
12.3.3 Chinese Peptide Company Lanreotide Acetate Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Chinese Peptide Company Lanreotide Acetate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Chinese Peptide Company Recent Developments
12.4 ZHEJIANG HUAJUN PHARMACEUTICAL
12.4.1 ZHEJIANG HUAJUN PHARMACEUTICAL Corporation Information
12.4.2 ZHEJIANG HUAJUN PHARMACEUTICAL Overview
12.4.3 ZHEJIANG HUAJUN PHARMACEUTICAL Lanreotide Acetate Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 ZHEJIANG HUAJUN PHARMACEUTICAL Lanreotide Acetate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 ZHEJIANG HUAJUN PHARMACEUTICAL Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Lanreotide Acetate Industry Chain Analysis
13.2 Lanreotide Acetate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Lanreotide Acetate Production Mode & Process
13.4 Lanreotide Acetate Sales and Marketing
13.4.1 Lanreotide Acetate Sales Channels
13.4.2 Lanreotide Acetate Distributors
13.5 Lanreotide Acetate Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Lanreotide Acetate Industry Trends
14.2 Lanreotide Acetate Market Drivers
14.3 Lanreotide Acetate Market Challenges
14.4 Lanreotide Acetate Market Restraints

15 Key Finding in The Global Lanreotide Acetate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Lanreotide Acetate Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of ≥98% Purity
Table 3. Major Manufacturers of Other
Table 4. Global Lanreotide Acetate Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Lanreotide Acetate Production by Region: 2016 VS 2021 VS 2027 (KG)
Table 6. Global Lanreotide Acetate Production by Region (2016-2021) & (KG)
Table 7. Global Lanreotide Acetate Production Market Share by Region (2016-2021)
Table 8. Global Lanreotide Acetate Production by Region (2022-2027) & (KG)
Table 9. Global Lanreotide Acetate Production Market Share by Region (2022-2027)
Table 10. Global Lanreotide Acetate Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Lanreotide Acetate Sales by Region (2016-2021) & (KG)
Table 12. Global Lanreotide Acetate Sales Market Share by Region (2016-2021)
Table 13. Global Lanreotide Acetate Sales by Region (2022-2027) & (KG)
Table 14. Global Lanreotide Acetate Sales Market Share by Region (2022-2027)
Table 15. Global Lanreotide Acetate Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Lanreotide Acetate Revenue Market Share by Region (2016-2021)
Table 17. Global Lanreotide Acetate Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Lanreotide Acetate Revenue Market Share by Region (2022-2027)
Table 19. Global Lanreotide Acetate Production Capacity by Manufacturers (2016-2021) & (KG)
Table 20. Global Lanreotide Acetate Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Lanreotide Acetate Production by Manufacturers (2016-2021) & (KG)
Table 22. Global Lanreotide Acetate Production Market Share by Manufacturers (2016-2021)
Table 23. Global Lanreotide Acetate Sales by Manufacturers (2016-2021) & (KG)
Table 24. Global Lanreotide Acetate Sales Share by Manufacturers (2016-2021)
Table 25. Global Lanreotide Acetate Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Lanreotide Acetate Revenue Share by Manufacturers (2016-2021)
Table 27. Lanreotide Acetate Price by Manufacturers 2016-2021 (US$/g)
Table 28. Global Lanreotide Acetate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Lanreotide Acetate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lanreotide Acetate as of 2020)
Table 30. Lanreotide Acetate Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Lanreotide Acetate Product Offered
Table 32. Date of Manufacturers Enter into Lanreotide Acetate Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Lanreotide Acetate Sales by Type (2016-2021) & (KG)
Table 35. Global Lanreotide Acetate Sales by Type (2022-2027) & (KG)
Table 36. Global Lanreotide Acetate Sales Share by Type (2016-2021)
Table 37. Global Lanreotide Acetate Sales Share by Type (2022-2027)
Table 38. Global Lanreotide Acetate Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Lanreotide Acetate Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Lanreotide Acetate Revenue Share by Type (2016-2021)
Table 41. Global Lanreotide Acetate Revenue Share by Type (2022-2027)
Table 42. Lanreotide Acetate Price by Type (2016-2021) & (US$/g)
Table 43. Global Lanreotide Acetate Price Forecast by Type (2022-2027) & (US$/g)
Table 44. Global Lanreotide Acetate Sales by Application (2016-2021) & (KG)
Table 45. Global Lanreotide Acetate Sales by Application (2022-2027) & (KG)
Table 46. Global Lanreotide Acetate Sales Share by Application (2016-2021)
Table 47. Global Lanreotide Acetate Sales Share by Application (2022-2027)
Table 48. Global Lanreotide Acetate Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Lanreotide Acetate Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Lanreotide Acetate Revenue Share by Application (2016-2021)
Table 51. Global Lanreotide Acetate Revenue Share by Application (2022-2027)
Table 52. Lanreotide Acetate Price by Application (2016-2021) & (US$/g)
Table 53. Global Lanreotide Acetate Price Forecast by Application (2022-2027) & (US$/g)
Table 54. North America Lanreotide Acetate Sales by Type (2016-2021) & (KG)
Table 55. North America Lanreotide Acetate Sales by Type (2022-2027) & (KG)
Table 56. North America Lanreotide Acetate Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Lanreotide Acetate Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Lanreotide Acetate Sales by Application (2016-2021) & (KG)
Table 59. North America Lanreotide Acetate Sales by Application (2022-2027) & (KG)
Table 60. North America Lanreotide Acetate Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Lanreotide Acetate Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Lanreotide Acetate Sales by Country (2016-2021) & (KG)
Table 63. North America Lanreotide Acetate Sales by Country (2022-2027) & (KG)
Table 64. North America Lanreotide Acetate Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Lanreotide Acetate Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Lanreotide Acetate Sales by Type (2016-2021) & (KG)
Table 67. Europe Lanreotide Acetate Sales by Type (2022-2027) & (KG)
Table 68. Europe Lanreotide Acetate Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Lanreotide Acetate Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Lanreotide Acetate Sales by Application (2016-2021) & (KG)
Table 71. Europe Lanreotide Acetate Sales by Application (2022-2027) & (KG)
Table 72. Europe Lanreotide Acetate Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Lanreotide Acetate Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Lanreotide Acetate Sales by Country (2016-2021) & (KG)
Table 75. Europe Lanreotide Acetate Sales by Country (2022-2027) & (KG)
Table 76. Europe Lanreotide Acetate Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Lanreotide Acetate Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Lanreotide Acetate Sales by Type (2016-2021) & (KG)
Table 79. Asia Pacific Lanreotide Acetate Sales by Type (2022-2027) & (KG)
Table 80. Asia Pacific Lanreotide Acetate Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Lanreotide Acetate Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Lanreotide Acetate Sales by Application (2016-2021) & (KG)
Table 83. Asia Pacific Lanreotide Acetate Sales by Application (2022-2027) & (KG)
Table 84. Asia Pacific Lanreotide Acetate Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Lanreotide Acetate Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Lanreotide Acetate Sales by Region (2016-2021) & (KG)
Table 87. Asia Pacific Lanreotide Acetate Sales by Region (2022-2027) & (KG)
Table 88. Asia Pacific Lanreotide Acetate Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Lanreotide Acetate Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Lanreotide Acetate Sales by Type (2016-2021) & (KG)
Table 91. Latin America Lanreotide Acetate Sales by Type (2022-2027) & (KG)
Table 92. Latin America Lanreotide Acetate Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Lanreotide Acetate Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Lanreotide Acetate Sales by Application (2016-2021) & (KG)
Table 95. Latin America Lanreotide Acetate Sales by Application (2022-2027) & (KG)
Table 96. Latin America Lanreotide Acetate Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Lanreotide Acetate Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Lanreotide Acetate Sales by Country (2016-2021) & (KG)
Table 99. Latin America Lanreotide Acetate Sales by Country (2022-2027) & (KG)
Table 100. Latin America Lanreotide Acetate Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Lanreotide Acetate Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Lanreotide Acetate Sales by Type (2016-2021) & (KG)
Table 103. Middle East and Africa Lanreotide Acetate Sales by Type (2022-2027) & (KG)
Table 104. Middle East and Africa Lanreotide Acetate Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Lanreotide Acetate Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Lanreotide Acetate Sales by Application (2016-2021) & (KG)
Table 107. Middle East and Africa Lanreotide Acetate Sales by Application (2022-2027) & (KG)
Table 108. Middle East and Africa Lanreotide Acetate Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Lanreotide Acetate Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Lanreotide Acetate Sales by Country (2016-2021) & (KG)
Table 111. Middle East and Africa Lanreotide Acetate Sales by Country (2022-2027) & (KG)
Table 112. Middle East and Africa Lanreotide Acetate Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Lanreotide Acetate Revenue by Country (2022-2027) & (US$ Million)
Table 114. Bachem Corporation Information
Table 115. Bachem Description and Major Businesses
Table 116. Bachem Lanreotide Acetate Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 117. Bachem Lanreotide Acetate Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Bachem Recent Development
Table 119. Jiangsu Sinopep Allsino Biopharmaceutical Corporation Information
Table 120. Jiangsu Sinopep Allsino Biopharmaceutical Description and Major Businesses
Table 121. Jiangsu Sinopep Allsino Biopharmaceutical Lanreotide Acetate Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 122. Jiangsu Sinopep Allsino Biopharmaceutical Lanreotide Acetate Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Jiangsu Sinopep Allsino Biopharmaceutical Recent Development
Table 124. Chinese Peptide Company Corporation Information
Table 125. Chinese Peptide Company Description and Major Businesses
Table 126. Chinese Peptide Company Lanreotide Acetate Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 127. Chinese Peptide Company Lanreotide Acetate Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Chinese Peptide Company Recent Development
Table 129. ZHEJIANG HUAJUN PHARMACEUTICAL Corporation Information
Table 130. ZHEJIANG HUAJUN PHARMACEUTICAL Description and Major Businesses
Table 131. ZHEJIANG HUAJUN PHARMACEUTICAL Lanreotide Acetate Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 132. ZHEJIANG HUAJUN PHARMACEUTICAL Lanreotide Acetate Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. ZHEJIANG HUAJUN PHARMACEUTICAL Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Lanreotide Acetate Distributors List
Table 137. Lanreotide Acetate Customers List
Table 138. Lanreotide Acetate Market Trends
Table 139. Lanreotide Acetate Market Drivers
Table 140. Lanreotide Acetate Market Challenges
Table 141. Lanreotide Acetate Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Lanreotide Acetate Product Picture
Figure 2. Global Lanreotide Acetate Market Share by Type in 2020 & 2027
Figure 3. ≥98% Purity Product Picture
Figure 4. Other Product Picture
Figure 5. Global Lanreotide Acetate Market Share by Application in 2020 & 2027
Figure 6. Acromegaly
Figure 7. Other
Figure 8. Lanreotide Acetate Report Years Considered
Figure 9. Global Lanreotide Acetate Capacity, Production and Utilization (2016-2027) & (KG)
Figure 10. Global Lanreotide Acetate Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Lanreotide Acetate Production Market Share by Region (2016-2021)
Figure 12. Global Lanreotide Acetate Production Market Share by Region (2022-2027)
Figure 13. Lanreotide Acetate Production Growth Rate in North America (2016-2027) & (KG)
Figure 14. Lanreotide Acetate Production Growth Rate in Europe (2016-2027) & (KG)
Figure 15. Lanreotide Acetate Production Growth Rate in China (2016-2027) & (KG)
Figure 16. Global Lanreotide Acetate Sales 2016-2027 (KG)
Figure 17. Global Lanreotide Acetate Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Lanreotide Acetate Revenue 2016-2027 (US$ Million)
Figure 19. Global Lanreotide Acetate Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 20. Global Lanreotide Acetate Sales Market Share by Region (2016-2021)
Figure 21. Global Lanreotide Acetate Sales Market Share by Region (2022-2027)
Figure 22. North America Lanreotide Acetate Sales YoY (2016-2027) & (KG)
Figure 23. North America Lanreotide Acetate Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Europe Lanreotide Acetate Sales YoY (2016-2027) & (KG)
Figure 25. Europe Lanreotide Acetate Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Asia-Pacific Lanreotide Acetate Sales YoY (2016-2027) & (KG)
Figure 27. Asia-Pacific Lanreotide Acetate Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Latin America Lanreotide Acetate Sales YoY (2016-2027) & (KG)
Figure 29. Latin America Lanreotide Acetate Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Middle East & Africa Lanreotide Acetate Sales YoY (2016-2027) & (KG)
Figure 31. Middle East & Africa Lanreotide Acetate Revenue YoY (2016-2027) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Lanreotide Acetate Sales in 2020
Figure 33. The Top 10 and Top 5 Players Market Share by Lanreotide Acetate Revenue in 2020
Figure 34. Lanreotide Acetate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 35. Global Lanreotide Acetate Sales Market Share by Type (2016-2027)
Figure 36. Global Lanreotide Acetate Revenue Market Share by Type (2016-2027)
Figure 37. Global Lanreotide Acetate Sales Market Share by Application (2016-2027)
Figure 38. Global Lanreotide Acetate Revenue Market Share by Application (2016-2027)
Figure 39. North America Lanreotide Acetate Sales Market Share by Type (2016-2027)
Figure 40. North America Lanreotide Acetate Revenue Market Share by Type (2016-2027)
Figure 41. North America Lanreotide Acetate Sales Market Share by Application (2016-2027)
Figure 42. North America Lanreotide Acetate Revenue Market Share by Application (2016-2027)
Figure 43. North America Lanreotide Acetate Sales Share by Country (2016-2027)
Figure 44. North America Lanreotide Acetate Revenue Share by Country (2016-2027)
Figure 45. United States Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 46. Canada Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 47. Europe Lanreotide Acetate Sales Market Share by Type (2016-2027)
Figure 48. Europe Lanreotide Acetate Revenue Market Share by Type (2016-2027)
Figure 49. Europe Lanreotide Acetate Sales Market Share by Application (2016-2027)
Figure 50. Europe Lanreotide Acetate Revenue Market Share by Application (2016-2027)
Figure 51. Europe Lanreotide Acetate Sales Share by Country (2016-2027)
Figure 52. Europe Lanreotide Acetate Revenue Share by Country (2016-2027)
Figure 53. Germany Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 54. France Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 55. U.K. Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 56. Italy Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 57. Russia Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 58. Asia Pacific Lanreotide Acetate Sales Market Share by Type (2016-2027)
Figure 59. Asia Pacific Lanreotide Acetate Revenue Market Share by Type (2016-2027)
Figure 60. Asia Pacific Lanreotide Acetate Sales Market Share by Application (2016-2027)
Figure 61. Asia Pacific Lanreotide Acetate Revenue Market Share by Application (2016-2027)
Figure 62. Asia Pacific Lanreotide Acetate Sales Share by Region (2016-2027)
Figure 63. Asia Pacific Lanreotide Acetate Revenue Share by Region (2016-2027)
Figure 64. China Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 65. Japan Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 66. South Korea Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 67. India Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 68. Australia Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 69. China Taiwan Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 70. Indonesia Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 71. Thailand Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 72. Malaysia Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 73. Latin America Lanreotide Acetate Sales Market Share by Type (2016-2027)
Figure 74. Latin America Lanreotide Acetate Revenue Market Share by Type (2016-2027)
Figure 75. Latin America Lanreotide Acetate Sales Market Share by Application (2016-2027)
Figure 76. Latin America Lanreotide Acetate Revenue Market Share by Application (2016-2027)
Figure 77. Latin America Lanreotide Acetate Sales Share by Country (2016-2027)
Figure 78. Latin America Lanreotide Acetate Revenue Share by Country (2016-2027)
Figure 79. Mexico Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 80. Brazil Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 81. Argentina Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 82. Middle East and Africa Lanreotide Acetate Sales Market Share by Type (2016-2027)
Figure 83. Middle East and Africa Lanreotide Acetate Revenue Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Lanreotide Acetate Sales Market Share by Application (2016-2027)
Figure 85. Middle East and Africa Lanreotide Acetate Revenue Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Lanreotide Acetate Sales Share by Country (2016-2027)
Figure 87. Middle East and Africa Lanreotide Acetate Revenue Share by Country (2016-2027)
Figure 88. Turkey Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 89. Saudi Arabia Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 90. UAE Lanreotide Acetate Revenue (2016-2027) & (US$ Million)
Figure 91. Lanreotide Acetate Value Chain
Figure 92. Lanreotide Acetate Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

---